AJOB的每一期都包含同行評議的目標(biāo)文章，這些文章集中討論了棘手的問題，由跨學(xué)科和跨文化的學(xué)者發(fā)表的公開評論文章予以回答。《美國生物倫理學(xué)雜志》提供了一個權(quán)威的、帶注釋的對話，被法官、參議員、記者、學(xué)者、教師和數(shù)百萬其他人用作衛(wèi)生科學(xué)數(shù)千個主題的關(guān)鍵來源。AJOB在生物倫理學(xué)出版方面引領(lǐng)潮流。數(shù)十萬讀者通過infocus的文章和其他的bioethics.net特性發(fā)現(xiàn)了生物倫理學(xué)。我們的讀者包括世界上幾乎每一所研究生院和專業(yè)學(xué)校的教員和學(xué)生，數(shù)以千計的當(dāng)選官員和法官，以及大多數(shù)健康新聞記者。《美國生物倫理學(xué)雜志》一直在關(guān)注建立生物倫理學(xué)的創(chuàng)新愿景：對生物醫(yī)學(xué)的社會影響的嚴(yán)肅討論。

Every issue of AJOB contains peer-reviewed Target Articles that zero in on tough questions, answered by Open Commentary articles from scholars across disciplines and cultures. The American Journal of Bioethics provides an authoritative, annotated conversation that has been used by judges, Senators, journalists, scholars, schoolteachers, and millions of others as the key source on thousands of topics in the health sciences. AJOB leads the way in bioethics publishing. Hundreds of thousands more readers have discovered bioethics through InFocus articles and other features of bioethics.net. Our readers include faculty and students at virtually every graduate and professional school in the world, thousands of elected officials and judges, and most health news journalists. The American Journal of Bioethics has followed through on the innovative vision that built bioethics: serious discussion of the social implications of biomedicine.